DE602005025402D1 - Tropfenpräparate mit dimetinden - Google Patents

Tropfenpräparate mit dimetinden

Info

Publication number
DE602005025402D1
DE602005025402D1 DE602005025402T DE602005025402T DE602005025402D1 DE 602005025402 D1 DE602005025402 D1 DE 602005025402D1 DE 602005025402 T DE602005025402 T DE 602005025402T DE 602005025402 T DE602005025402 T DE 602005025402T DE 602005025402 D1 DE602005025402 D1 DE 602005025402D1
Authority
DE
Germany
Prior art keywords
dimetindes
free
drops
drop preparations
preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005025402T
Other languages
English (en)
Inventor
Julien Rousset
Eric Turin
Michel Steiger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602005025402D1 publication Critical patent/DE602005025402D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DE602005025402T 2004-08-11 2005-08-10 Tropfenpräparate mit dimetinden Active DE602005025402D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417909.9A GB0417909D0 (en) 2004-08-11 2004-08-11 Drop preparations
PCT/EP2005/008697 WO2006015861A2 (en) 2004-08-11 2005-08-10 Drop preparations comprising dimetindene

Publications (1)

Publication Number Publication Date
DE602005025402D1 true DE602005025402D1 (de) 2011-01-27

Family

ID=33017338

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005025402T Active DE602005025402D1 (de) 2004-08-11 2005-08-10 Tropfenpräparate mit dimetinden

Country Status (10)

Country Link
US (1) US20070287722A1 (de)
EP (1) EP1830801B1 (de)
AT (1) ATE491438T1 (de)
BR (1) BRPI0514205A2 (de)
DE (1) DE602005025402D1 (de)
ES (1) ES2356828T3 (de)
GB (1) GB0417909D0 (de)
PL (1) PL1830801T3 (de)
PT (1) PT1830801E (de)
WO (1) WO2006015861A2 (de)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998000168A1 (en) * 1996-07-02 1998-01-08 Novartis Consumer Health S.A. Topical composition comprising a combination of antihistaminic compounds with terpenoid compounds
WO1998001134A1 (en) * 1996-07-10 1998-01-15 Novartis Consumer Health S.A. Oral pharmaceutical combinations of antihistaminic compounds and terpenoids
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup

Also Published As

Publication number Publication date
PL1830801T3 (pl) 2011-05-31
WO2006015861A3 (en) 2006-09-28
BRPI0514205A2 (pt) 2009-03-10
WO2006015861A2 (en) 2006-02-16
PT1830801E (pt) 2010-12-27
ATE491438T1 (de) 2011-01-15
GB0417909D0 (en) 2004-09-15
ES2356828T3 (es) 2011-04-13
EP1830801A2 (de) 2007-09-12
US20070287722A1 (en) 2007-12-13
EP1830801B1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
WO2005067893A3 (en) Pharmaceutical compositions comprising midazolam in a high concentration
WO2005115406A3 (en) 8-(2-hydroxyphenoxy)octyldiethanolamine and salts thereof for delivery of active agents
NO20083630L (no) Nye pyridinderivater
CL2013000261A1 (es) Compuestos derivados de heterociclos nitrogenados, con actividad ampk; composicion farmaceutica; metodos in vitro; y su uso en enfermedades cardiovasculares, diabetes tipo ii, distrofia muscular, trastornos neurolgicos, enfermedades inflamatorias, entre otras.
WO2008128049A3 (en) Tetrahydrobiopterin compositions and methods of measuring
EA201170703A1 (ru) Производные адамантилбензамида
WO2006131591A3 (en) An entacapone-containing oral dosage form
EA200702589A1 (ru) 2,6-хинолинильные производные, способы их получения и их применение
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
DK2439267T3 (da) Enzympræparater, der giver en ren smag
FR2910230B3 (fr) Methodes de biofertilisations pour ameliorer la stabilite des rendements de grandes cultures agronomiques.
WO2010021607A3 (en) Pharmaceutical formulation
ATE427039T1 (de) Tee-aromatisierung
NO20062605L (no) Farmasoytisk formulering inneholdende smakssubstanser med forbedrede farmasoytiske egenskaper
DE502007005902D1 (de) -methyl-19-nor-20- spirox-4-en-3-one), sowie diese enthaltende pharmazeutische präparate
EA201070484A1 (ru) Новые конъюгаты нейртурина для фармацевтического применения
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
DK2185561T3 (da) Derivater af 1,2,3,4-tetrahydropyrrolo(1,2-a)pyrazin-6-carboxamid og 2,3,4,5-tetrahydroprrolo(1,2-a)-diazepin-7-carboxamid, fremstilling deraf og terapeutisk anvendelse deraf
BRPI0913401A2 (pt) pregn-4 eno-21, 17-carbolactonas substituídas no anel c e preparados farmacêuticos contendo as mesmas
CY2011018I1 (el) Νεα κρυσταλλικη μορφη toy 8-kyan-1-kykλoπpoπyλ-7-(1s,6s-2,8-διαζαδικυκλο[4.3.0]εννεαν-8-υλ)-6-φθορο-1,4-διυδρο-4-οξο-3-κινολινο-καρβοξυλικου οξεος
SE0300457D0 (sv) Novel compounds
DE602005025402D1 (de) Tropfenpräparate mit dimetinden
WO2007121883A3 (de) 1,4:3,6-dianhydromannitol-derivate und deren verwendung
DK1922320T3 (da) Derivater af 5-pyridazinyl-1-azabicyclo[3.2.1]octan, fremstilling deraf og anvendelse deraf i terapi
WO2010047826A3 (en) Dosing regimens and dosage formulations of an antiviral peptide therapeutic